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Abstract  
Neoangiogenesis is a response to retinal hypoxia that is inhibited by somatostatin (SRIF) 
through its subtype 2 receptor (sst2). Using a mouse model of hypoxia-induced retinopathy, 
we investigated the possibility that inhibition of adenylyl cyclase (AC) is involved in SRIF 
anti-angiogenic actions. Hypoxia increased AC responsiveness in wild type (WT) retinas and 
in retinas lacking sst2, but not in sst2-overexpressing retinas. Hypoxia also altered AC 
isoform expression, but with different patterns depending on sst2 expression level. Among the 
nine AC isoforms, AC VII isoform mRNA and protein resulted the most affected. Indeed, in 
hypoxia AC VII expression was significantly enhanced in WT retinas and it was further 
increased in sst2-lacking retinas, but not in retinas overexpressing sst2. These data suggest an 
involvement of AC/cAMP in mediating both hypoxia-evoked retinal neoangiogenesis and 
SRIF protective actions. The AC VII isoform is a candidate to a main role in these 
mechanisms. 
Key words: somatostatin; adenylyl cyclase system; hypoxia; mouse retina; transgenic mice. 
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Introduction 
Proliferative retinopathy is characterized by the generation of proangiogenic factors 
resulting in excessive proliferation of new blood vessels within the retina [1,2]. Other 
molecules, acting as antiangiogenic factors, can regulate the angiogenic process [1]. Several 
lines of experimental and clinical evidence indicate that somatostatin (SRIF) and its analogues 
may act as antiangiogenic factors [3-7]. 
Although the mechanisms underlying SRIF antiangiogenic actions remain to be 
elucidated, it has been proposed that this peptide acts both directly, by inhibiting endothelial 
cell proliferation, and indirectly through a reduction of the release of proangiogenic factors, 
such as vascular endothelial growth factor (VEGF) [8-10]. 
SRIF binds to five different subtypes of heterotrimeric G-protein coupled receptors, 
which have been cloned and termed sst1 through sst5 [11]. The transduction pathways 
influenced by SRIF receptors have been poorly characterized in mammalian retinas, however 
an inhibition of adenylyl cyclase (AC) activity by SRIF has been described in the mouse 
retina [12], indicating that retinal pathways activated by SRIF are likely to be the same as 
those of other nervous or non-nervous tissues. Indeed, although each receptor subtype can 
influence different signal transduction pathways, all five receptors are functionally coupled to 
AC inhibition [13] leading to a reduction of intracellular adenosine 3’,5’cyclic AMP (cAMP).  
Nine AC isoforms (AC I-IX) have been cloned [14] and all, with the exception of AC 
VII, have been reported in mammalian retinas [15,16]. Taken together, these observations 
indicate that AC inhibition may be implicated in SRIF antiangiogenic actions in the retina. 
Consistently, activation of cAMP pathway has been reported to result in proangiogenic effects 
in a variety of experimental models [17-20]. 
Among SRIF receptors, sst2 is likely to be responsible for SRIF antiangiogenic actions 
in the retina. Indeed, sst2 preferring agonists inhibit neovascularization in proliferative 
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diabetic retinopathy [6,7] and counteract growth factor-induced proliferation of bovine retinal 
endothelial cells under hypoxic conditions [3]. 
We have recently employed transgenic mice to investigate the involvement of sst2 in 
mediating SRIF antiangiogenic actions. In particular, sst1 knockout (KO) mice are a model of 
sst2 overexpression [22-24], while sst2 KO mice are a model of null sst2 expression. Using 
retinas from these mice in a model of hypoxia-induced retinopathy, we have demonstrated 
that neovascularization and VEGF expression significantly increase in the absence of sst2 
[21], while VEGF expression is significantly reduced when sst2 is overexpressed [21]. In the 
present work, using sst1 or sst2 KO mice and the model of hypoxia-induced retinopathy, we 
investigated the hypothesis of a correlation between sst2 expression, AC activity and AC 
isoform expression, supporting a role for the AC/cAMP system in mediating SRIF 
antiangiogenic effects through sst2. 
 
Experimental Procedure 
 
Animals 
 
Experiments were performed on retinas from normoxic and hypoxic mice of WT 
(C57BL/6) and sst1 or sst2 KO strains of both sexes. sst1 and sst2 KO mice were generated as 
previously reported [25,26]. Hypoxic mice were obtained utilizing the hypoxia-induced 
retinopathy model described by Smith et al. [27]. Briefly, the model was produced in newborn 
mouse pups at postnatal day (PD)7 by exposure to 75% oxygen for five days and subsequent 
recovery in a room-air environment. After the transfer of pups to a normoxic condition (PD 
12), the developing relative retinal hypoxia led to induction of abnormal vasoproliferation that 
reached a maximum at PD 17. Mice kept in room air were used as controls (normoxia). At PD 
 5 
17, normoxic and hypoxic mice were sacrificed and retinas were dissected, as described [21]. 
Mice were nursed in the animal house of the Department of Biology at the University of Pisa 
and maintained in controlled environment with food and water ad libitum. All the animal 
studies were performed according to the guidelines and approval of the ARVO Statement for 
the Use of Animals in Ophthalmic and Vision Research and in compliance with the Italian law 
on animal care N°116/1992 and the EEC/609/86. All efforts were made to reduce the number 
of animals used. 
 
Membrane preparations 
 
Normoxic and hypoxic retinas, dissected from WT and transgenic mice at PD 17, were 
teased from the pigment epithelium and maintained in ice-cold buffer (10 mM Hepes/Tris, 
10% sucrose, pH 7.4). Retinas (12 per vial) were then frozen in liquid nitrogen and stored at -
80°C. The thawed retinas were homogenized using a Dounce homogenizer in the same ice-
cold buffer. The homogenate was centrifuged at 1,000 g for 10 min, the supernatant was 
aspirated and stored. The pellet was re-suspended, re-homogenized, and centrifuged as above. 
The two supernatants were combined and centrifuged at 11,000 g for 20 min. The pellet was 
re-suspended in 30 ml of ice-cold buffer without sucrose and centrifuged at 27,000 g for 10 
min. Finally, the pellet was re-suspended in the same buffer supplemented with the protease 
inhibitors aprotinin (20 μg/ml) and leupeptin (20 μg/ml) and used immediately. All steps of 
the above procedure were performed at 4°C. Protein concentration was determined according 
to Bradford [28], using bovine serum albumin as a standard. 
 
Measurements of AC activity 
 
AC activity was measured as previously reported [12]. Briefly, the standard assay 
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mixture (0.4 ml/tube) contained: 75 mM Hepes/Tris, 1 mM MgSO4, 10 μM 3-isobutyl-1-
methylxanthine (IBMX), 500 μM GTP, 1 mM EGTA, pH 7.4, plus 50 μg of membrane 
protein/tube and test substances, when indicated. Membranes were preincubated for 20 min at 
0°C, the reaction was then initiated by the addition of 500 μM ATP, carried out for 10 min at 
30°C and stopped by 2 min of boiling. After centrifugation of samples, cAMP was measured 
on the clear supernatant, according to the method of Brown et al. [29]. Each experiment was 
performed in duplicate. The data were expressed as pmol cAMP/mg protein/10 min. 
 
RNA preparation, cDNA synthesis, and real time PCR analysis 
 
 
Total RNA was extracted from 6 retinas of PD 17 normoxic and hypoxic WT and KO 
mice, using the RNeasy Mini Kit (Qiagen, Valencia, CA), according to the manufacturer’s 
recommended procedure. RNA samples were treated with DNase to remove traces of genomic 
DNA, solubilized in RNase-free water and quantified by spectrophotometric analysis. The 
samples were checked for integrity using formaldehyde denaturing RNA gel electrophoresis 
(1.2%) before proceeding with the further real time PCR analysis. cDNA synthesis was 
performed with 1 g of total RNA using iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, 
USA) in a final volume of 20 l, according to the manufacturer’s protocol. Real time PCR 
was performed using SYBR Green on MiniOpticon System (Bio-Rad). The final reaction 
mixture contained 1 l of cDNA, 300 nM of each primer, 7.5 l of iQ SYBR green Supermix 
(Bio-Rad), and RNase-free water to complete the reaction mixture volume to 15 l. Primer 
sequences are shown in Table I. Negative control reactions were set up as above without any 
template cDNA. All reactions were run as triplicates. The PCR was performed with hot-start 
denaturation step at 95°C for 3 min, and then was carried out for 40 cycles at 95°C for 10 sec 
and 58°C for 20 sec. The fluorescence was read during the reaction, allowing a continuous 
monitoring of the amount of PCR product. Dissociation curve analysis was performed for 
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quality control with data collection from a subsequent temperature ramp from 65°C to 95°C. 
Real time PCR products were analyzed on a GelStar (Cambrex, East Rutherford, NJ)-
containing 3% agarose gel to verify the correct product sizes. Products identity was confirmed 
by automated DNA sequencing (ABI PRISM 3130 Applera, Applied Biosystems). The 
efficiency of target amplification had values close to 100% for all primer combinations. The 
comparative Ct (threshold cycle) method normalized to cyclophilin B, a stable mRNA in our 
experimental conditions, was used to analyze relative changes in gene expression as 
previously described (amount of target = 2
- Ct
) [32].  
 
Immunohistochemistry 
 
The eyes were removed from normoxic and hypoxic WT and KO animals at PD 17 
and immersion fixed in 2% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4, for 2 
h. The fixed eyes were transferred to 25% sucrose in 0.1 M PB and stored at 4°C. The retinas 
were cut with the whole eye in a plane perpendicular to the vitreal surface at 10 μm with a 
cryostat. The sections were mounted onto gelatin-coated slides and stored at -20°C. For 
immunohistochemical detection of AC VII, sections from normoxic as well as hypoxic WT 
and KO retinas were washed in 0.1 M PB and incubated overnight at 4°C in AC VII 
antibodies (sc-25501) diluted 1:400 in 0.1 M PB containing 1% Triton X-100. Following 
washes in 0.1 M PB, the sections were incubated in secondary antibody conjugated with 
Alexa Fluor 546 at a dilution of 1:200 in 0.1 M PB containing 0.5% Triton X-100 for 1-2 
hours at room temperature (RT). Then, the slides were coverslipped in a 0.1 M PB-glycerin 
mixture. In control experiments, where the primary antibody was omitted, no unspecific 
staining was observed in any retinal layer. Immunofluorescence images were acquired with a 
laser confocal scanning microscope (Leica Microsystems Heidelberg GmbH, Mannheim, 
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Germany). The digital images were sized and saved at a minimum of 300 dpi using Adobe 
Photoshop (Adobe Systems, Mountain View, CA).  
 
Statistical analysis 
 
Data were examined by unpaired t test or ANOVA, followed by Dunnett’s comparison 
post test, as appropriate. Differences were considered statistically significant at p < 0.05. The 
software PRISM (version 4.0, Graph Pad Software Inc., San Diego, CA) was used. All data 
are reported as means ± SEM. 
 
Chemicals 
 
[8-
3H]adenosine 3’-5’-cyclic phosphate (specific activity 24 Ci/mmol) was from 
Amersham Biosciences, GE Healthcare UK Ltd, Little Chalfont, England. Aprotinin, 
leupeptin, IBMX, GTP, cAMP, ATP, EGTA, FSK, SRIF and epinephrine were from Sigma, St. 
Louis, MO. Octreotide (OCTR) was provided from Novartis, Basel, Switzerland. AC VII 
antibody (sc-25501) was from Santa Cruz Biotechnology, Santa Cruz, CA. Secondary 
antibody conjugated with Alexa Fluor 546 was  from Molecular Probes, Eugene, OR. 
 
Results 
 
Adenylyl cyclase activity 
 
AC activity measured on membrane preparations is reported in Table II. In normoxic 
retinas, AC basal activity was similar in WT and sst1 KO, but it was significantly reduced in 
sst2 KO retinas (-21%). The enzyme was potently stimulated by FSK and it was also activated 
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by epinephrine, whose receptors, positively coupled to AC, are expressed in the rodent retina 
[33]. FSK-stimulated AC activity was insensitive to SRIF or OCTR in WT and in sst2 KO 
retinas while, as expected [12], SRIF or OCTR greatly reduced FSK-stimulated AC activity (-
47% and -51%, respectively) in sst1 KO retinas. FSK and epinephrine concentration (1 μM) 
was chosen on the basis of dose-response curves (data not shown). SRIF and OCTR were 
utilized at 1 μM, according to our previous results [12]. Overall, the observations in normoxic 
retinas were in agreement with those reported by Pavan et al. [12]. 
In hypoxic retinas, AC basal activity was significantly enhanced with respect to 
normoxic in sst2 KO retinas (+65%). In addition, the enzyme responsiveness to FSK and 
epinephrine was significantly increased both in WT (+26%, +34%, respectively) and in sst2 
KO (+90%, +158%, respectively), but not in sst1 KO retinas. Similar to normoxic, also in 
hypoxic retinas SRIF or OCTR did not affect FSK-stimulated AC activity in WT or in sst2 
KO retinas. In contrast, in sst1 KO hypoxic retinas both SRIF and OCTR greatly decreased 
FSK-stimulated AC activity (-48%, -56%, respectively) and the recorded values were not 
different from those in normoxic retinas. 
In summary, the hypoxic treatment caused a massive increase of FSK- or epinephrine-
stimulated AC activity both in WT and in sst2 KO retinas. In addition, in these retinas FSK-
stimulated AC activity was not influenced by either SRIF or OCTR. In contrast, FSK- or 
epinephrine-stimulated AC activity in sst1 KO retinas subjected to hypoxic treatment tended 
to remain similar to that in normoxic retinas, and the inhibition of the FSK-stimulated AC 
activity by SRIF or OCTR persisted. 
 
Adenylyl cyclase isoform mRNA expression 
 
In order to find possible correlates of AC activity changes in the different experimental 
conditions described above, a real time PCR analysis was performed to determine the 
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expression levels of  AC isoforms in normoxic and in hypoxic mouse retinas. Preliminary 
experiments performed on PD 17 WT normoxic mice showed that all AC isoform (AC I-IX) 
transcripts are expressed in the retina (Fig. 1).  
The relative levels of all transcripts in normoxic and hypoxic conditions normalized to 
cyclophilin B were evaluated (Fig. 2). As shown in Fig. 2A, in normoxic retinas the genetic 
deletion of sst1 did not alter AC isoform expression pattern versus WT. In contrast, when 
compared to WT, in sst2 KO retinas a statistically significant reduction of the mRNAs for 
some AC isoforms (AC II, III, VI and IX, -29%, -37%, -43%, -40%, respectively) was 
detected. 
The analysis of retinas in hypoxic conditions (Fig. 2B) revealed a significantly 
different expression pattern of AC isoforms. In particular, in WT retinas mRNA expression of 
AC II, III and V significantly decreased (-25%, -27%, -28%, respectively), whereas AC VII 
mRNA expression highly increased (+103%) with respect to normoxic retinas. In sst1 KO 
retinas, AC III and IX mRNAs significantly decreased (-30% and -27%, respectively), 
whereas AC VII and VIII mRNA expression significantly increased (+41% and +38%, 
respectively). In sst2 KO retinas, AC V mRNA underwent a statistically significant decrease 
(-24%), whereas a statistically significant increase of mRNAs for AC I, VI, VII and VIII was 
observed (+41%, +48%, +169%, and +34%, respectively).  
In summary, the hypoxic treatment induced significant changes in the pattern of AC 
isoform expression in the retinas of all three mouse strains. The most apparent modifications 
were at the level of AC VII, whose expression was greatly increased in all strains, although 
the enhancement in sst1 KO retinas was significantly (?) less marked than in WT or in sst2 
KO retinas. 
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Immunohistochemistry 
 
As shown by the real time PCR results, the AC VII isoform appears to be the most 
affected by hypoxic treatment. This AC isoform has not been reported previously in 
mammalian retinas, therefore we performed an immunohistochemical analysis to localize this 
AC isoform and support the real time PCR data. In addition, although immunohistochemistry 
is not a reliable quantitative technique, we checked whether the hypoxia-induced alterations 
could be observed in immunostained retinal sections. 
As shown in Fig. 3A, the pattern of AC VII immunofluorescence in normoxic WT 
retinas was characterized by punctate staining, which was mainly confined to the 
photoreceptor outer segments, the outer plexiform layer (OPL), the inner plexiform layer and 
the ganglion cell layer. Similar patterns of AC VII immunoreactivity could be observed in 
normoxic sst1 KO and sst2 KO retinas. However, as shown in Fig. 3B-D, these patterns 
appeared to be differentially affected by hypoxic treatment. Indeed, a slight but evident 
increase of AC VII immunofluorescence intensity was observed in hypoxic WT retinas with 
respect to their normoxic controls, particularly in the OPL (Fig. 3B). In contrast, no apparent 
differences were detected between normoxic and hypoxic sst1 KO retinas (Fig. 3C). Finally, 
in sst2 KO retinas a considerable increase of AC VII immunofluorescence intensity could be 
seen after hypoxic treatment in all retinal layers containing AC immunoreactivity (Fig. 3D).  
Together, these changes in AC VII immunofluorescence were in line with those in AC 
VII mRNA expression observed with real time PCR. 
 
Discussion 
In the present study, we have provided evidence of correlations between hypoxic 
conditions, levels of sst2 expression and alterations of the AC/cAMP system, suggesting an 
involvement of this transduction pathway in sst2-mediated antiangiogenic actions of SRIF. 
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These data also confirm and expand previous studies regarding AC/cAMP system modulation 
by SRIF and in the mouse retina [12]. 
In addition to WT retinas, we have utilized retinas from transgenic mice were sst2 are 
either overexpressed and overfunctional (the sst1 KO retinas) [12,23], or absent (the sst2 KO 
retinas). These genetically modified strains represent useful experimental models to 
investigate the role of such receptor in mediating SRIF responses. A central part of our study 
has been concerned with measurements of AC activity in response to SRIF or OCTR. To 
detect the effects of these substances, AC was stimulated by FSK. Indeed, as previously 
reported in the retina as well as in other different tissues, SRIF effects on AC activity become 
well evident when this activity is sustained by stimulators, among which FSK [12,34,35]. 
 
SRIF and the AC/cAMP system in normoxic retinas 
The data of AC activity in normoxic retinas are in line with those of our previous 
studies [12]. Basal AC activity was similar in WT and sst1 KO retinas, whereas a reduction 
was observed in sst2 KO retinas. AC responsiveness to stimulators such as FSK or 
epinephrine was similar in all strains, however AC inhibition by SRIF or OCTR was only 
observed in sst1 KO retinas. As previously reported, this effect is likely to be due to a better 
coupling between sst2 and Gαo, since both sst2 and G protein expressions are increased in 
sst1 KO retinas [12,23]. 
Our data show that the mRNAs of all nine AC isoforms are present in the different 
strains, however AC VII isoform has not been reported previously in mammalian retinas 
[15,16]. The lack of evidence of AC VII mRNA in previous studies may be due to different 
species used as experimental models, or to different experimental protocols. To our 
knowledge, this is the first report of AC VII in the mouse retina both at the mRNA and at the 
protein level, which substantiates the presence of AC VII in the mouse retina.  
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The AC mRNA expression patterns were not different in sst1 KO with respect to WT 
retinas, whereas a reduction of expression was evident for several AC isoform mRNAs in sst2 
KO retinas. These results indicate that the pattern of AC isoform expression is highly 
influenced by sst2 deletion, but not sst1 deletion with consequent sst2 overexpression. At 
present, it is difficult to explain why an alteration of sst expression results in a change of the 
availability of AC system components. Our previous observations showed an increased 
expression of Gαo in mouse retinas with sst1 deletion [12]. In addition, it has been clearly 
demonstrated that an altered functionality of Gαi/o-coupled receptors, sst included, may 
induce modifications of the expression of various AC transduction system components, 
including catalytic subunits [36]. The decreased expression of some AC isoforms in sst2 KO 
retinas may explain the decrease of enzyme basal activity with respect to WT retinas. 
 
SRIF and the AC/cAMP system in hypoxic retinas 
Concerning the data on AC activity in hypoxic conditions, the most evident finding is 
that the hypoxic treatment significantly increased AC responsiveness to FSK and epinephrine 
in WT and in sst2 KO retinas. In the latter, an enhancement of the enzyme activity was also 
evident in basal conditions. It is important to note that, in contrast, stimulated AC activity was 
not significantly affected in the presence of sst2 overexpression, as in sst1 KO retinas. 
Moreover, while SRIF or OCTR treatment was ineffective in WT or in sst2 KO retinas, it 
decreased AC activity in sst1 KO retinas to levels that were not significantly different from 
those measured in similarly treated sst1 KO normoxic retinas. Together, these observations 
indicate that overexpression of sst2, as in sst1 KO retinas, counteracts the effects of hypoxia 
on AC activity, while lack of sst2 amplifies these effects. 
The analysis of AC isoform mRNA expression in hypoxic WT retinas showed a 
decrease of AC II, III, and V expression, but a great enhancement of AC VII mRNA with 
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respect to normoxic WT retinas. Alterations of AC isoform expression in response to oxygen 
deficiency have been observed in different tissues [37,38]. In sst1 or sst2 KO retinas, the 
combination of hypoxia and sst2 expression level resulted in strain-specific changes. 
Noteworthy, AC VII mRNA expression increased in all strains, but to a lesser extent in sst1 
KO and to a higher extent in sst2 KO retinas, if compared to the enhancement in WT. These 
changes in AC VII mRNA expression were substantiated by our immunofluorescence data 
showing concordant variations in immunofluorescence intensity. At present we have no 
plausible explanation for these changes observed in sst1 and sst2 KO retinas in hypoxic 
conditions. However, further alterations of sst2 expression can be excluded, since we 
previously demonstrated that hypoxia does not alter per se sst2 expression [21]. 
It has been demonstrated that the AC VII isoform is highly responsive to stimulatory 
agents, and insensitive to all known inhibitory regulators, Gαi/o included [39]. Therefore, its 
enhanced expression could be mostly responsible for the observed in vitro increase in AC 
responsiveness to stimulators. Since it has been reported that hypoxia increases the release of 
AC stimulatory agents, such as catecholamines and adenosine, as well as their receptor 
expression [40-42], AC VII isoform may play a central role in the enhancement of cAMP in 
these conditions.  
The increased cAMP level in hypoxia is likely to be instrumental to the induction of 
neoangiogenesis and the increased expression of proangiogenic factors such as VEGF, that we 
have observed recently in all three strains, in the same experimental model. In particular, 
compared to WT retinas, both angiogenesis and VEGF expression are increased in sst2 KO, 
while VEGF expression is decreased in sst1 KO retinas [21]. Together, these findings suggest 
that an enhanced somatostatinergic function at sst2 protects against the production of 
proangiogenic cAMP, while sst2 deletion results in an opposite condition. 
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Conclusion 
In conclusion, we have investigated the AC/cAMP transduction pathway in an in vivo 
model of retinal hypoxia using retinas from WT mice and from mice with over- or null sst2 
expression. We observed changes of both AC activity and expression in response to hypoxia. 
Most importantly, these changes could be correlated with different levels of sst2 expression, 
as the patterns of AC activity or AC isoform expression were different in WT, sst1 KO or sst2 
KO retinas. These data provide evidence in support of an involvement of the AC/cAMP 
system in mediating not only hypoxia-evoked retinal neoangiogenesis, but also SRIF 
protective actions. The AC VII isoform is a candidate to a main role in these mechanisms. 
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Captions to the Figures 
 
Fig. 1. AC isoform mRNA expression in PD 17 WT normoxic retinas. Total RNA was 
extracted from the retinas, reverse transcribed, and real time PCR performed with isoform-
specific primers as described in Materials and Methods. M: DNA Marker 50 bp ladder; Lane 
1: AC type I; Lane 2: AC type II; Lane 3: AC type III; Lane 4: AC type IV; Lane 5: AC type 
V; Lane 6: AC type VI; Lane 7: AC type VII; Lane 8: AC type VIII; Lane 9: AC type IX. 
 
Fig. 2. AC isoform mRNA expression by real time PCR in WT (white bars), sst1 KO (black 
bars) and sst2 KO (grey bars) mouse retinas. 
A: AC isoforms expression level in normoxic conditions Each panel shows the ratio between 
optical density (OD) of AC mRNA isoform and cyclophilin B mRNA in normoxic (white bar) 
and hypoxic (black bar) retinas from the three mouse strains. Representative agarose gel 
electrophoresis of PCR for AC isoforms and relative control loading cyclophilin B (Cyc) 
amplicons is shown in the top of each panel. Data are means ± SEM of at least six 
independent experiments. ◦ p < 0.05 vs WT normoxic (ANOVA, followed by Dunnett's post 
test); * p < 0.05 vs relative normoxic condition (unpaired t test); § p < 0.05 vs WT hypoxic 
(ANOVA, followed by Dunnett's post test).  
 
Fig. 3.  A: pattern of AC VII immunofluorescence in a WT, normoxic mouse retina.  punctate 
immunolabeling was densely distributed to the photoreceptor outer segments (POS) and it 
was evident in the outer plexiform layer (OPL), in the inner plexiform layer (IPL) and in the 
ganglion cell layer (GCL). B-D: AC VII immunostaining patterns in WT (B), sst1 KO (C) and 
sst2 KO (D) retinas in normoxic (left half of each panel) or in hypoxic (right half of each 
panel) conditions. A detectable increase of immunofluorescence intensity can be appreciated 
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after hypoxic treatment in WT retinas; no changes are seen in sst1 KO retinas; an evident 
increase is seen in sst2 KO retinas. All images are single confocal optical sections. INL, inner 
nuclear layer; ONL, outer nuclear layer. Scale bars: 20 μm. 
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